CLINICAL_TRIALS
trial_result
· 2014-10-30
Clinical Trial Update: Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia [Phase 2]
Summary
A Phase 2 trial assessing the efficacy and safety of CNV2197944 versus placebo in patients with post-herpetic neuralgia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Convergence Pharmaceuticals | Conditions: Post-herpetic Neuralgia | Phase 2 | Status: COMPLETED